| 000 | 01080 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250516113035.0 | ||
| 264 | 0 | _c20130225 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1600-6143 | ||
| 024 | 7 |
_a10.1111/j.1600-6143.2012.04229.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLimaye, A P | |
| 245 | 0 | 0 |
_aReasons for breakthrough CMV disease in patients who receive preemptive therapy. _h[electronic resource] |
| 260 |
_bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _cOct 2012 |
||
| 300 |
_a2858 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _gvol. 12 _gno. 10 _gp. 2858 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-6143.2012.04229.x _zAvailable from publisher's website |
| 999 |
_c22133027 _d22133027 |
||